FAKTOR-OPTIONSSCHEIN - ORION B | Market Closed - Börse Stuttgart 15:11:21 2024-06-07 EDT | ||
| 6.91 EUR | -0.14% |
|
| Current month | -7.00% | ||
| 1 month | -14.90% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ORION OYJ
Latest news about ORION OYJ
More news
| Date | Price | Change |
|---|---|---|
| 24-06-07 | 6.91 | -0.14% |
| 24-06-06 | 6.92 | +1.91% |
| 24-06-05 | 6.79 | -0.73% |
| 24-06-04 | 6.84 | -3.93% |
| 24-06-03 | 7.12 | -4.17% |
Delayed Quote Börse Stuttgart
Last update June 07, 2024 at 03:11 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | ORION OYJ |
| Issuer | Morgan Stanley |
| WKN | MG2WH4 |
| ISIN | DE000MG2WH42 |
| Date issued | 2024-04-24 |
| Strike | 58.26 € |
| Maturity | Unlimited |
| Parity | 2.8 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 9.88 € |
|---|---|
| Lowest since issue | 6.79 € |
| Spread | 0.01 € |
| Spread % | 0.14% |
Company Profile
Orion Oyj is Finland's leading pharmaceutical group. Net sales break down by family products and services as follows:
- generic, OTC and biosimilar drugs (43.4%);
- patented prescription products (41.7%): notably intended for treating dysfunctions of the nervous system, cardiovascular diseases, hormonal and urological treatments;
- animal health products (8.7%);
- pharmaceutical ingredients and outsourcing services (6.2%).
Net sales break down primarily by source of revenue between sales of products (86.9%) and royalties (10.4%).
Net sales are distributed geographically as follows: Finland (28%), Scandinavia (12%), Europe (30.8%), North America (14.7%) and other (14.5%).
Sector
-
Consensus: Orion Oyj
Sell
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
38.94
EUR
Average target price
39
EUR
Spread / Average Target
+0.15%
- Stock Market
- Certificates
- Certificat
